LeBel Carl

Chief Development Officer at KRRO; Chief Scientific Officer at Otonomy, Inc.

Sold, on record
$1.7M
Dollars the filings state
Form 4 sales
8
Latest Jul 6, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
4
Plan not stated
0
No plan
4
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Otonomy, Inc.Unusual
    Sep 21, 2015 2015

    Sold 21,250 shares at $24.36 ($518k)

    LeBel Carl, Chief Scientific Officer

    Sold 70.4% of holdings ($735k position)8,920 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Otonomy, Inc.Unusual
    Dec 21, 2015 +91 days

    Sold 21,250 shares at $28.04 ($596k)

    LeBel Carl, Chief Scientific Officer

    Sold 70.4% of holdings ($846k position)8,920 shares leftFiling

  3. 3 Form 4 sale Otonomy, Inc.Unusual
    Sep 6, 2016 +260 days

    Sold 21,250 shares at $17.95 ($381k)

    LeBel Carl, Chief Scientific Officer

    Sold 69.2% of holdings ($551k position)9,458 shares leftFiling

  4. 4 Form 4 sale Otonomy, Inc.Unusual
    Nov 21, 2016 +76 days

    Sold 10,625 shares at $18.07 ($192k)

    LeBel Carl, Chief Scientific Officer

    Sold 52.9% of holdings ($363k position)9,458 shares left0.5x usual sizeFiling

  5. 5 Form 4 sale KRROPlan not stated
    Feb 15, 2022 +1912 days

    Sold 844 shares at $4.33 ($4k)

    LeBel Carl, Chief Development Officer

    Sold 5.4% of holdings ($68k position)14,901 shares leftFirst sale on recordFiling

  6. 6 Form 4 sale KRROPlan not stated
    Feb 17, 2022 +2 days

    Sold 1,732 shares at $4.31 ($7k)

    LeBel Carl, Chief Development Officer

    Sold 11.6% of holdings ($64k position)13,169 shares leftFiling

  7. 7 Form 4 sale KRROPlan not stated
    Feb 22, 2022 +5 days

    Sold 2,043 shares at $3.69 ($8k)

    LeBel Carl, Chief Development Officer

    Sold 15.5% of holdings ($49k position)11,126 shares leftFiling

  8. 8 Form 4 sale KRROPlan not stated
    Jul 6, 2022 +134 days

    Sold 4,421 shares at $1.52 ($7k)

    LeBel Carl, Chief Development Officer

    Sold 14.4% of holdings ($47k position)26,343 shares left2.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by LeBel Carl
Source
Jul 6, 2022Jul 7, 2022KRROChief Development OfficerForm 4 sale4,421$7k14.4%Plan not statedSEC
Feb 22, 2022Feb 23, 2022KRROChief Development OfficerForm 4 sale2,043$8k15.5%Plan not statedSEC
Feb 17, 2022Feb 18, 2022KRROChief Development OfficerForm 4 sale1,732$7k11.6%Plan not statedSEC
Feb 15, 2022Feb 16, 2022KRROChief Development OfficerForm 4 sale844$4k5.4%Plan not statedSEC
Nov 21, 2016Nov 22, 2016Otonomy, Inc.Chief Scientific OfficerForm 4 sale10,625$192k52.9%UnusualSEC
Sep 6, 2016Sep 8, 2016Otonomy, Inc.Chief Scientific OfficerForm 4 sale21,250$381k69.2%UnusualSEC
Dec 21, 2015Dec 22, 2015Otonomy, Inc.Chief Scientific OfficerForm 4 sale21,250$596k70.4%UnusualSEC
Sep 21, 2015Sep 22, 2015Otonomy, Inc.Chief Scientific OfficerForm 4 sale21,250$518k70.4%UnusualSEC